Axfood AB (AXFO)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 273.50 |
|---|---|
| 52-week range | 222.07 – 328.31 |
| Return, 1 month / 3 months | +10.1% / +19.3% |
| Return, 1 year / 3 years | −1.0% / +19.9% |
| Trend | Below its 200-day average |
| RSI (14) | 75 |
| Volatility (1 year) | 28.2% |
| Worst drawdown (1 year) | -31.7% |
| Average daily value traded | 99.66M SEK |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Axfood is a Swedish food retail and wholesale group based in Stockholm. It runs supermarket and convenience store chains, including Willys and Hemköp, serving everyday shoppers across Sweden. Through its wholesale and logistics arm, the company supplies groceries to independent retailers and its own stores, managing distribution and sourcing for a wide range of food and household products. Its business spans retail stores, wholesale supply and related food operations for customers in the Swedish grocery market.
The shares are listed on the Stockholm Exchange in Sweden under the code AXFO, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Axfood AB (AXFO) trades on the Stockholm Exchange in Sweden. It last closed at SEK 273.50 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 230 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.0% and over the last three months it rose 19.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.0% | ||
| From 52-week high | -16.4% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 19.3% | ||
| 6-month return | -13.2% | ||
| 12-month return, skipping the last month | -10.0% | ||
| Stability (higher is calmer) | 74 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.7% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 99.66M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +6.1% |
|---|---|
| 1 month | +10.1% |
| 3 months | +19.3% |
| 6 months | −13.2% |
| 1 year | −1.0% |
| 3 years | +19.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 246.92 / 273.61 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Sep 2026 | SEK 4.5000 |
| 19 Mar 2026 | SEK 4.5000 |
| 18 Sep 2025 | SEK 4.2500 |
| 20 Mar 2025 | SEK 4.5000 |
| 19 Sep 2024 | SEK 4.2500 |
| 21 Mar 2024 | SEK 4.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.